浙江医药(600216.SH)：拟推2025年限制性股票激励计划

Core Points - Zhejiang Medicine (600216.SH) announced a restricted stock incentive plan for 2025, proposing to grant a total of no more than 10.284 million shares of restricted stock to incentive targets, which accounts for approximately 1.0694% of the company's total share capital at the time of the announcement of the draft incentive plan [1]